D
Emergent BioSolutions Inc. EBS
$5.71 $0.203.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 1.04B 1.13B 1.10B 1.19B 1.05B
Total Other Revenue -- -- -- -- --
Total Revenue 1.04B 1.13B 1.10B 1.19B 1.05B
Cost of Revenue 667.60M 716.80M 765.30M 659.60M 688.60M
Gross Profit 376.00M 408.70M 336.90M 525.80M 360.70M
SG&A Expenses 298.70M 327.40M 331.20M 345.20M 356.70M
Depreciation & Amortization 65.10M 65.00M 65.00M 64.80M 65.60M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.10B 1.22B 1.27B 1.18B 1.22B
Operating Income -51.60M -89.50M -165.10M 10.00M -167.40M
Income Before Tax -142.90M -169.80M -578.10M -558.50M -731.20M
Income Tax Expenses 47.70M 39.00M 8.90M 6.80M 29.30M
Earnings from Continuing Operations -190.60 -208.80 -587.00 -565.30 -760.50
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -190.60M -208.80M -587.00M -565.30M -760.50M
EBIT -51.60M -89.50M -165.10M 10.00M -167.40M
EBITDA 54.00M 19.50M -54.90M 124.60M -46.30M
EPS Basic -3.63 -4.00 -11.25 -11.02 -14.90
Normalized Basic EPS -1.30 -1.69 -3.02 -1.01 -3.03
EPS Diluted -3.73 -4.11 -11.25 -11.03 -14.91
Normalized Diluted EPS -1.35 -1.73 -3.02 -1.01 -3.03
Average Basic Shares Outstanding 212.10M 209.80M 208.50M 206.60M 204.60M
Average Diluted Shares Outstanding 214.60M 212.30M 208.50M 206.60M 204.60M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings